Lev Facher covers substance use and addiction. His reporting has explored Americans' deadly hostility to addiction medications, subpar treatment offered in jails and prisons, shifts in the illicit drug supply and consumption behavior, controversies surrounding harm reduction, and recent innovations in addiction medicine.
Lev has worked at STAT since 2016, previously as a Washington correspondent focused on prescription drug pricing, federal biomedical research agencies, and the government's response to Covid-19. He's best reached by email or on Signal: @levfacher.51.
Journalistic ethics: Lev adheres to the standards outlined in the STAT ethics policy. STAT is committed to truth, accuracy, impartiality, and transparency in our reporting.
